CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review (Q35606333)

9 August 2017

1 reference

title

CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review (English)

1 reference

9 August 2017

1 reference

8

E Matutes

1 reference

9 August 2017

M C Béné

1

1 reference

9 August 2017

G Castoldi

2

1 reference

9 August 2017

W Knapp

3

1 reference

9 August 2017

G M Rigolin

4

1 reference

9 August 2017

L Escribano

5

1 reference

9 August 2017

P Lemez

6

1 reference

9 August 2017

W-D Ludwig

7

1 reference

9 August 2017

A Orfao

9

1 reference

9 August 2017

F Lanza

10

1 reference

9 August 2017

M van't Veer

11

1 reference

9 August 2017

EGIL, European Group on Immunological Classification of Leukemias

12

1 reference

9 August 2017

1 March 2004

1 reference

9 August 2017

1 reference

9 August 2017

18

1 reference

9 August 2017

394-400

1 reference

9 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403250

9 August 2017

0 references

cites work

Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Regulation of integrin function by the urokinase receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

uPAR: a versatile signalling orchestrator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

The urokinase receptor is required for human monocyte chemotaxis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Urokinase-type plasminogen activator receptor (CD87) is a ligand for integrins and mediates cell-cell interaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

The role of the plasminogen system in bone resorption in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

M5, a phosphoinositol-linked human myelomonocytic activation-associated antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Expression of the receptor for urokinase-type plasminogen activator in normal and neoplastic blood cells and hematopoietic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Soluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Urokinase-type plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Proteolysis of the urokinase-type plasminogen activator receptor by metalloproteinase-12: implication for angiogenesis in fibrin matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

Function of the urokinase receptor (CD87) in neutrophil chemotaxis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

The intact urokinase receptor is required for efficient vitronectin binding: receptor cleavage prevents ligand interaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

Cellular glycosylphosphatidylinositol-specific phospholipase D regulates urokinase receptor shedding and cell surface expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

A soluble form of the urokinase plasminogen activator receptor (suPAR) can bind to hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

Expression and functional role of urokinase-type plasminogen activator receptor in normal and acute leukaemic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage- cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403250

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403250

1 reference

release_sb5576qh3fhahnwd6yac447gva

9 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/sb5576qh3fhahnwd6yac447gva

24 November 2022

mapped directly with Wikidata item

1 reference